AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH) Cash From Operations

Annual CFO:

$44.39M+$77.85M(+232.66%)
December 31, 2024

Summary

  • As of today, AUPH annual cash from operations is $44.39 million, with the most recent change of +$77.85 million (+232.66%) on December 31, 2024.
  • During the last 3 years, AUPH annual cash from operations has risen by +$202.08 million (+128.15%).
  • AUPH annual cash from operations is now at all-time high.

Performance

AUPH Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Quarterly CFO:

$44.99M-$85.40K(-0.19%)
September 30, 2025

Summary

  • As of today, AUPH quarterly cash from operations is $44.99 million, with the most recent change of -$85.40 thousand (-0.19%) on September 30, 2025.
  • Over the past year, AUPH quarterly cash from operations has increased by +$28.03 million (+165.35%).
  • AUPH quarterly cash from operations is now -0.19% below its all-time high of $45.07 million, reached on June 30, 2025.

Performance

AUPH Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

TTM CFO:

$120.62M+$28.03M(+30.28%)
September 30, 2025

Summary

  • As of today, AUPH TTM cash from operations is $120.62 million, with the most recent change of +$28.03 million (+30.28%) on September 30, 2025.
  • Over the past year, AUPH TTM cash from operations has increased by +$91.59 million (+315.46%).
  • AUPH TTM cash from operations is now at all-time high.

Performance

AUPH TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AUPH Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+232.7%+165.3%+315.5%
3Y3 Years+128.2%+419.8%+205.8%
5Y5 Years+169.8%+249.7%+221.4%

AUPH Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+128.2%-0.2%+242.1%at high+205.8%
5Y5-Yearat high+128.2%-0.2%+184.0%at high+176.9%
All-TimeAll-Timeat high+128.2%-0.2%+184.0%at high+176.9%

AUPH Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$44.99M(-0.2%)
$120.62M(+30.3%)
Jun 2025
-
$45.07M(+3367.1%)
$92.59M(+46.1%)
Mar 2025
-
$1.30M(-95.6%)
$63.38M(+45.8%)
Dec 2024
$44.39M(+232.7%)
$29.27M(+72.6%)
$43.48M(+49.8%)
Sep 2024
-
$16.95M(+6.9%)
$29.03M(+2375.8%)
Jun 2024
-
$15.86M(+185.3%)
-$1.28M(+93.6%)
Mar 2024
-
-$18.60M(-225.5%)
-$20.09M(+39.4%)
Dec 2023
-$33.46M(+57.9%)
$14.82M(+210.9%)
-$33.16M(+7.5%)
Sep 2023
-
-$13.36M(-353.1%)
-$35.85M(+2.0%)
Jun 2023
-
-$2.95M(+90.7%)
-$36.56M(+40.2%)
Mar 2023
-
-$31.67M(-361.2%)
-$61.19M(+19.8%)
Dec 2022
-$79.53M(+49.6%)
$12.12M(+186.2%)
-$76.26M(+33.1%)
Sep 2022
-
-$14.07M(+49.0%)
-$114.04M(+17.5%)
Jun 2022
-
-$27.57M(+41.0%)
-$138.21M(+7.9%)
Mar 2022
-
-$46.75M(-82.2%)
-$150.04M(+4.3%)
Dec 2021
-$157.69M(-125.7%)
-$25.65M(+32.9%)
-$156.83M(-21.5%)
Sep 2021
-
-$38.24M(+2.9%)
-$129.04M(-6.8%)
Jun 2021
-
-$39.40M(+26.4%)
-$120.85M(-17.5%)
Mar 2021
-
-$53.54M(-2601.7%)
-$102.84M(-43.0%)
Dec 2020
-$69.86M(-9.9%)
$2.14M(+107.1%)
-$71.91M(+27.6%)
Sep 2020
-
-$30.05M(-40.5%)
-$99.37M(-22.0%)
Jun 2020
-
-$21.39M(+5.4%)
-$81.46M(-11.2%)
Mar 2020
-
-$22.61M(+10.7%)
-$73.25M(-14.8%)
Dec 2019
-$63.59M(-23.2%)
-$25.32M(-108.5%)
-$63.79M(-23.4%)
Sep 2019
-
-$12.15M(+7.8%)
-$51.71M(-2.2%)
Jun 2019
-
-$13.17M(-0.2%)
-$50.57M(-2.3%)
Mar 2019
-
-$13.15M(+0.7%)
-$49.42M(+2.4%)
Dec 2018
-$51.61M(-25.4%)
-$13.24M(-20.3%)
-$50.65M(-5.5%)
Sep 2018
-
-$11.01M(+8.4%)
-$48.01M(-2.1%)
Jun 2018
-
-$12.02M(+16.4%)
-$47.04M(-0.7%)
Mar 2018
-
-$14.38M(-35.7%)
-$46.70M(-11.1%)
Dec 2017
-$41.17M(-120.0%)
-$10.60M(-5.5%)
-$42.03M(-19.0%)
Sep 2017
-
-$10.04M(+14.0%)
-$35.31M(-20.2%)
Jun 2017
-
-$11.68M(-20.2%)
-$29.38M(-27.3%)
Mar 2017
-
-$9.71M(-150.5%)
-$23.08M(-24.2%)
Dec 2016
-$18.71M(-5.3%)
-$3.88M(+5.5%)
-$18.58M(+4.1%)
Sep 2016
-
-$4.10M(+23.7%)
-$19.38M(+2.4%)
Jun 2016
-
-$5.38M(-3.0%)
-$19.86M(-9.0%)
Mar 2016
-
-$5.22M(-11.6%)
-$18.22M(-7.0%)
Dec 2015
-$17.77M(-13.1%)
-$4.68M(-1.9%)
-$17.02M(-11.8%)
Sep 2015
-
-$4.59M(-23.0%)
-$15.23M(-3.7%)
Jun 2015
-
-$3.73M(+7.2%)
-$14.69M(+3.0%)
Mar 2015
-
-$4.02M(-39.5%)
-$15.14M(+0.9%)
Dec 2014
-$15.71M(-262.3%)
-$2.88M(+28.9%)
-$15.28M(-4.0%)
Sep 2014
-
-$4.05M(+3.1%)
-$14.68M(-20.8%)
Jun 2014
-
-$4.18M(-0.6%)
-$12.15M(-46.5%)
Mar 2014
-
-$4.16M(-81.7%)
-$8.29M(-91.3%)
Dec 2013
-$4.33M(+33.5%)
-$2.29M(-50.3%)
-$4.33M(-48.6%)
Sep 2013
-
-$1.52M(-369.8%)
-$2.92M(-14.7%)
Jun 2013
-
-$324.00K(-61.2%)
-$2.54M(+48.8%)
Mar 2013
-
-$201.00K(+76.9%)
-$4.97M(+24.4%)
Dec 2012
-$6.52M
-$869.30K(+24.3%)
-$6.57M(+5.2%)
Sep 2012
-
-$1.15M(+58.2%)
-$6.93M(+1.0%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$2.75M(-52.3%)
-$7.01M(-22.6%)
Mar 2012
-
-$1.80M(-46.5%)
-$5.71M(-322.4%)
Dec 2011
-$1.40M(+68.6%)
-$1.23M(-1.0%)
-$1.35M(-58.7%)
Sep 2011
-
-$1.22M(+16.2%)
-$852.20K(+22.6%)
Jun 2011
-
-$1.46M(-157.0%)
-$1.10M(-81.8%)
Mar 2011
-
$2.56M(+449.2%)
-$605.40K(+86.6%)
Dec 2010
-$4.45M(+53.6%)
-$731.90K(+50.2%)
-$4.53M(+16.6%)
Sep 2010
-
-$1.47M(-52.9%)
-$5.43M(-2.4%)
Jun 2010
-
-$960.50K(+29.7%)
-$5.30M(+37.5%)
Mar 2010
-
-$1.37M(+16.5%)
-$8.49M(+18.2%)
Dec 2009
-$9.60M(+51.6%)
-$1.64M(-21.9%)
-$10.38M(-4.1%)
Sep 2009
-
-$1.34M(+67.6%)
-$9.96M(+7.1%)
Jun 2009
-
-$4.15M(-27.4%)
-$10.72M(-1.5%)
Mar 2009
-
-$3.25M(-166.3%)
-$10.56M(+39.6%)
Dec 2008
-$19.83M(+24.5%)
-$1.22M(+41.7%)
-$17.47M(+26.8%)
Sep 2008
-
-$2.10M(+47.4%)
-$23.87M(+21.5%)
Jun 2008
-
-$3.99M(+60.8%)
-$30.40M(+7.7%)
Mar 2008
-
-$10.17M(-33.4%)
-$32.94M(-14.6%)
Dec 2007
-$26.26M(-21.5%)
-$7.62M(+11.7%)
-$28.74M(-6.5%)
Sep 2007
-
-$8.63M(-32.2%)
-$26.99M(-17.5%)
Jun 2007
-
-$6.53M(-9.6%)
-$22.98M(-9.6%)
Mar 2007
-
-$5.96M(-1.4%)
-$20.97M(+2.5%)
Dec 2006
-$21.61M(-6.2%)
-$5.88M(-27.4%)
-$21.52M(-2.0%)
Sep 2006
-
-$4.61M(-1.9%)
-$21.11M(-8.1%)
Jun 2006
-
-$4.53M(+30.4%)
-$19.52M(+6.1%)
Mar 2006
-
-$6.50M(-19.1%)
-$20.78M(+1.1%)
Dec 2005
-$20.35M(-9.3%)
-$5.46M(-80.5%)
-$21.00M(+8.5%)
Sep 2005
-
-$3.03M(+47.7%)
-$22.94M(+8.6%)
Jun 2005
-
-$5.79M(+13.9%)
-$25.10M(-6.2%)
Mar 2005
-
-$6.73M(+9.1%)
-$23.64M(-19.1%)
Dec 2004
-$18.61M(-291.5%)
-$7.40M(-42.7%)
-$19.85M(-46.8%)
Sep 2004
-
-$5.19M(-20.0%)
-$13.52M(-13.2%)
Jun 2004
-
-$4.32M(-47.3%)
-$11.94M(-150.7%)
Mar 2004
-
-$2.94M(-173.3%)
-$4.76M(+5.8%)
Dec 2003
-$4.75M(-458.0%)
-$1.07M(+70.2%)
-$5.06M(+32.8%)
Sep 2003
-
-$3.61M(-226.4%)
-$7.53M(-3242.4%)
Jun 2003
-
$2.85M(+188.4%)
$239.50K(+111.3%)
Mar 2003
-
-$3.23M(+8.8%)
-$2.12M(-149.2%)
Dec 2002
-$852.10K(+88.6%)
-$3.54M(-185.2%)
-$852.30K(-311.9%)
Sep 2002
-
$4.16M(+745.6%)
$402.30K(+112.3%)
Jun 2002
-
$491.60K(+125.1%)
-$3.28M(+48.7%)
Mar 2002
-
-$1.96M(+14.3%)
-$6.40M(+12.3%)
Dec 2001
-$7.45M(-25.0%)
-
-
Dec 2001
-
-$2.29M(-581.0%)
-$7.30M(-45.6%)
Sep 2001
-
$475.40K(+118.1%)
-$5.01M(+8.7%)
Jun 2001
-
-$2.63M(+8.1%)
-$5.49M(-91.9%)
Mar 2001
-
-$2.86M(-318.6%)
-$2.86M(-110.8%)
Dec 2000
-$5.96M(-344.8%)
-
-
Nov 1999
-$1.34M(+26.1%)
-$682.90K(-3852.2%)
-$1.36M(-101.5%)
Aug 1999
-
$18.20K(+102.5%)
-$673.10K(+2.6%)
May 1999
-
-$731.70K(-1911.1%)
-$691.30K(-1811.1%)
Feb 1999
-
$40.40K
$40.40K
Nov 1998
-$1.81M
-
-

FAQ

  • What is Aurinia Pharmaceuticals Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. annual cash from operations year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. quarterly cash from operations year-on-year change?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Aurinia Pharmaceuticals Inc.?
  • What is Aurinia Pharmaceuticals Inc. TTM cash from operations year-on-year change?

What is Aurinia Pharmaceuticals Inc. annual cash from operations?

The current annual cash from operations of AUPH is $44.39M

What is the all-time high annual cash from operations for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high annual cash from operations is $44.39M

What is Aurinia Pharmaceuticals Inc. annual cash from operations year-on-year change?

Over the past year, AUPH annual cash from operations has changed by +$77.85M (+232.66%)

What is Aurinia Pharmaceuticals Inc. quarterly cash from operations?

The current quarterly cash from operations of AUPH is $44.99M

What is the all-time high quarterly cash from operations for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high quarterly cash from operations is $45.07M

What is Aurinia Pharmaceuticals Inc. quarterly cash from operations year-on-year change?

Over the past year, AUPH quarterly cash from operations has changed by +$28.03M (+165.35%)

What is Aurinia Pharmaceuticals Inc. TTM cash from operations?

The current TTM cash from operations of AUPH is $120.62M

What is the all-time high TTM cash from operations for Aurinia Pharmaceuticals Inc.?

Aurinia Pharmaceuticals Inc. all-time high TTM cash from operations is $120.62M

What is Aurinia Pharmaceuticals Inc. TTM cash from operations year-on-year change?

Over the past year, AUPH TTM cash from operations has changed by +$91.59M (+315.46%)
On this page